????? ????? ???? ??????(???????) ?? ??? ??? ??????? ??????? ?? ???? ???? ????????

Phase 3

Recruiting

• Conditions: Traumatic brain injury.; Diffuse traumatic brain injury; S06.2

• Registration Number: IRCT20240415061495N1
• Lead Sponsor: Oroumia University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 962

Inclusion Criteria

Patients with traumatic brain injury were between 15 and 60 years old
GCS between 7 and 11
intubation
No history of brain damage, seizures, high blood pressure, ischemic heart disease and diabetes
No addiction to psychedelics and narcotics or Amphetamine use
Heart rate less than 120 beats per minute

Exclusion Criteria

Evidence of drug allergy
Patients who could not tolerate enteral feeding despite maximal medical treatment in the first 48 hours of admission

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
GCS SCORE. Timepoint: The third day after receiving the medicine on a daily basis. Method of measurement: GCS score table.;APACHE II score. Timepoint: rom the third day of hospitalization, starting with Ritalin - daily. Method of measurement: APACHE II Table.

Secondary Outcome Measures

Name	Time	Method
ength of hospitalization of patients. Timepoint: From the first day until discharge from the hospital. Method of measurement: Number of days of hospitalization.;Patient extubation time. Timepoint: From the time of hospitalization and intubation until the patient is extubated. Method of measurement: Duration of extubation.